Work

AML-547 Prognostic Effect of Co-Mutations on Patients With NPM1+ Acute Myeloid Leukemia (AML) Enrolled in the Connect® Myeloid Registry

Year: 2023

Type: conference-abstract

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(23)01079-0

Authors: Jaroslaw Maciejewski, Daniel Pollyea, Gail Roboz, Karen Seiter, Bart Scott, Irene DeGutis, Pavel Kiselev, Edward Yu, Ali McBride, Willem Heydendael, Harry Erba

Institutions: Cleveland Clinic, University of Colorado Anschutz, University of Colorado Denver, NewYork–Presbyterian Hospital, Weill Cornell Medicine, New York Medical College, Medical College of Wisconsin, Fred Hutch Cancer Center, Bristol-Myers Squibb (United States), Duke University

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Bristol-Myers Squibb

OpenAlex ID: W4386282361

Cites:

Cited by:

Related to: 10